TP53 and gastric cancer: We have used the RSM assay and the ESR technique to analyse gastritis and intestinal metaplasia samples to address the issue of whether genetic alteration of p53 is an early or late event in gastric carcinogenesis, and to obtain a direct measure of free radical levels (on separate tissue samples) at each stage in the sequence of events leading to gastric cancer.